Bioprocess Sciences And Technology Of Viral Vaccines

病毒疫苗生物过程科学与技术

• 批准号: CRC-2014-00006
• 负责人: Kamen, Amine
• 金额: $ 7.29万
• 依托单位: McGill University
• 依托单位国家: 加拿大
• 项目类别: Canada Research Chairs
• 财政年份: 2021
• 资助国家: 加拿大
• 起止时间: 2021-01-01 至 2022-12-31
• 项目状态: 已结题
• 来源: https://www.nserc-crsng.gc.ca/ase-oro/Details-Detailles_eng.asp?id=729437
• 关键词: Bioprocess; Sciences; Technology; Viral; Vaccines

Vaccination is one of the most successful and cost-effective health interventions known. As immunization strategies have advanced, the methods to produce vaccines have evolved and new vaccine opportunities have been created. Modern vaccine development is currently exploiting progress in recombinant DNA technology and cell culture platforms to produce safer, more efficacious and cost-effective vaccines, including viral vectors and viral-like particles vaccines.The research program of the CRC ¿Bioprocess Sciences and Technology of Viral Vaccines¿ has been designed to address critical challenges in bioprocessing of cell culture-produced viral vaccines to accelerate the development of advanced manufacturing technologies and train highly needed qualified personnel.

疫苗接种是已知的最成功和最具成本效益的健康干预措施之一。随着免疫策略的进步，生产疫苗的方法也不断发展，并创造了新的疫苗机会。现代疫苗开发目前正在利用重组DNA技术和细胞培养平台的进展来生产更安全、更有效和更具成本效益的疫苗，包括病毒载体和病毒样颗粒疫苗。CRC“病毒疫苗生物过程科学和技术”的研究计划旨在解决细胞培养生产的病毒疫苗生物加工中的关键挑战，以加速先进先进疫苗的开发。 制造技术并培训急需的合格人才。